Source: Annual Congress 2003 - Management of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. M. Panescu, C. C. Vasilescu, M. M. Archip (Iasi, Romania). On abandon of the tuberculosis treatment. Eur Respir J 2003; 22: Suppl. 45, 3255

Member's Comments

No comment yet.

Related content which might interest you: Rimfampicin importance in tuberculosis treatment Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008 Has the time come to shorten TB treatment and TB preventive therapy? Source: Virtual Congress 2021 – Respiratory infections Year: 2021 Re-think first-line tuberculosis treatment Source: Eur Respir J 2013; 41: 488-489 Year: 2013 How did the tuberculosis patients reach to a tuberculosis dispensary and how long did it take? Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011 A new era for treatment of drug-resistant tuberculosis Source: Eur Respir J, 52 (4) 1801350; 10.1183/13993003.01350-2018 Year: 2018 Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is “blind” treatment dangerous? Source: Eur Respir J 2011; 37: 1283-1285 Year: 2011 Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008 The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses Source: Eur Respir J 2001; 18: Suppl. 33, 473s Year: 2001 Management of multidrug-resistant tuberculosis and patients in retreatment Source: Eur Respir J 2005; 25: 928-936 Year: 2005 Bedaquiline for the treatment of multidrug-resistant tuberculosis: another missed opportunity? Source: Eur Respir J, 49 (5) 1700738; 10.1183/13993003.00738-2017 Year: 2017 Diaskintest at patients after successful treatment of lung tuberculosis Source: International Congress 2017 – Migrants and screening Year: 2017 The continued hunt for the elusive standard short regimen for treatment of multidrug-resistant tuberculosis Source: Eur Respir J, 55 (3) 2000224; 10.1183/13993003.00224-2020 Year: 2020 Experience of isofon use for therapy and chemoprophylaxis of tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 486s Year: 2004 Effect on treatment of giving information about tuberculosis to the tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 644s Year: 2005 Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection. Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Surgical treatment of first found pulmonary tuberculosis at ineffectiveness of DOTS therapy Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions Year: 2011 Treatment of TB Source: Eur Respir Mon 2012; 58: 154-166 Year: 2012 The causes of ineffectiveness of treatment of tuberculosis in children Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005 New immunologic tools for the diagnosis and therapy of tuberculosis Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005